Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Animal or plant cell
Reexamination Certificate
2008-01-01
2008-01-01
Saucier, Sandra E. (Department: 1651)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Animal or plant cell
Reexamination Certificate
active
07314617
ABSTRACT:
Methods are described for using compositions containing platelet-rich plasma for the treatment of a variety of tissue lesions. Particularly, delivery of platelet-rich plasma to connective tissue is described. The described method and compositions have been shown to provide both pain relief and improved mobility in treatment of lateral epicondylitis.
REFERENCES:
patent: 4663289 (1987-05-01), Veech
patent: 4931395 (1990-06-01), Griffin
patent: 5079236 (1992-01-01), Drizen et al.
patent: 5124316 (1992-06-01), Antoniades et al.
patent: 5147776 (1992-09-01), Koerner, Jr.
patent: 5165938 (1992-11-01), Knighton
patent: 5178883 (1993-01-01), Knighton
patent: 5385937 (1995-01-01), Stamler et al.
patent: 5403272 (1995-04-01), Deniega et al.
patent: 5449688 (1995-09-01), Wahl et al.
patent: 5474891 (1995-12-01), Murphy
patent: 5494590 (1996-02-01), Smith et al.
patent: 5510102 (1996-04-01), Cochrum
patent: 5578565 (1996-11-01), Chao et al.
patent: 5585007 (1996-12-01), Antanavich et al.
patent: 5599558 (1997-02-01), Gordinier et al.
patent: 5614204 (1997-03-01), Cochrum
patent: 5643786 (1997-07-01), Cohen et al.
patent: 5788662 (1998-08-01), Antanavich et al.
patent: 5834418 (1998-11-01), Brazeau et al.
patent: 5905142 (1999-05-01), Murray
patent: 5935850 (1999-08-01), Clark et al.
patent: 6098631 (2000-08-01), Holoshitz et al.
patent: 6183442 (2001-02-01), Athanasiou et al.
patent: 6214338 (2001-04-01), Antanavich et al.
patent: 6242594 (2001-06-01), Kelly
patent: 6280473 (2001-08-01), Lemperle et al.
patent: 6306171 (2001-10-01), Conzemius
patent: 6315992 (2001-11-01), Noh et al.
patent: 6322785 (2001-11-01), Landesberg et al.
patent: 6432119 (2002-08-01), Saadat
patent: 6454804 (2002-09-01), Ferree
patent: 6712851 (2004-03-01), Lemperle et al.
patent: 6811777 (2004-11-01), Mishra
patent: 6905612 (2005-06-01), Dorian et al.
patent: 2001/0031978 (2001-10-01), Kipke et al.
patent: 2002/0006437 (2002-01-01), Grooms et al.
patent: 2002/0032155 (2002-03-01), Ferree
patent: 2002/0058030 (2002-05-01), Monroy et al.
patent: 2002/0082220 (2002-06-01), Hoemann et al.
patent: 2003/0116512 (2003-06-01), Delbert Antwiller et al.
patent: 2003/0152639 (2003-08-01), Britton et al.
patent: 2003/0185812 (2003-10-01), Ferree
patent: 2003/0192554 (2003-10-01), Ferree
patent: 2003/0205538 (2003-11-01), Dorian et al.
patent: 2003/0236573 (2003-12-01), Evans et al.
patent: 2004/0126885 (2004-07-01), Cines et al.
patent: 2004/0182795 (2004-09-01), Dorian et al.
patent: 2004/0220101 (2004-11-01), Ferree
patent: 2004/0220102 (2004-11-01), Ferree
patent: 2004/0244806 (2004-12-01), Ferree
patent: 2005/0043738 (2005-02-01), Ryan
patent: 2005/0064042 (2005-03-01), Vunjak-Novakovic et al.
patent: 2005/0186193 (2005-08-01), Mishra
patent: 2006/0029578 (2006-02-01), Hoemann et al.
patent: 2006/0041243 (2006-02-01), Nayak et al.
patent: 2006/0127382 (2006-06-01), Mishra
patent: 2006/0235306 (2006-10-01), Cotter et al.
patent: 2006/0263407 (2006-11-01), Mishra
patent: 2007/0014784 (2007-01-01), Nayak et al.
patent: 2007/0042016 (2007-02-01), Nayak et al.
patent: 2007/0110737 (2007-05-01), Mishra
patent: 2007/0122906 (2007-05-01), Mishra
patent: 2007/0172472 (2007-07-01), Nayak
patent: 0 142 339 (1985-05-01), None
patent: 0 417 818 (1991-03-01), None
patent: WO 00/01427 (2000-01-01), None
patent: WO 03/015800 (2003-02-01), None
patent: WO 2004/022078 (2004-03-01), None
patent: WO 2005/065242 (2005-07-01), None
Feurstein et al., “Congestive heart failure and genomic medicine: a look into the 21st century”, Cardiovascular Drugs and Therapy 11 (6) : 713-7 (1997).
McCarthy, “New surgical options for the failing heart”, Journal of Heart Valve Disease 8 (5) : 472-5 (1999).
Knebel et al., “Heart failure: state of the art treatment and options”, Clinical nephrology 60 (Suppl. 1) : S59-S66 (2003).
Shim et al., “Stem cell cardiomyoplasty: state of the art”, Annals of the Academy of Medicine, Singapore 33 (4) : 451-60 (2004).
Snyder, et al. “Calcium-Dependent Proteolysis of Actin During Storage of Platelet Concentrates,”Blood, vol. 73, No. 5, pp. 1380-1385, 1989.
Tang, et al., “The Effects of pCO2 and pH on Platelet Shape Change and Aggregation for Human and Rabit Platelet-Rich Plasma,”Thrombosis Research, vol. 10, No. 1, pp. 135-145, 1977.
Edwards, et al. “Autologous Blood Injections for Refractory Lateral Epicondylitis,”The Journal of Hand Surgery, vol. 28A, No. 2, pp. 272-278, Mar. 2003.
Gruber, et al. “Platelets Stimulate Proliferation of Bone Cells: Involvement of Platelet-Derived Growth Factor, Microparticles and Membranes,”Clin. Oral Impl. Res, vol. 13, pp. 529-535, 2002.
Marx, et al. “Platelet-Rich Plasma, Growth Factor Enhancement for Bone Grafts,”Oral Surgery Oral Medicine Oral Pathology, vol. 85, No. 6, pp. 638-646, Jun. 1998.
Cohen, et al. “Wound Care and Wound Healing,” inPrinciples of Surgery, Chapter 8, (Seymore, et al. eds.) pp. 263-295, New York, 1999.
Taylor, et al. “The Response of Rabbit Patellar Tendons After Autologous Blood Injection,”Medicine&Science in Sports&Exercise, vol. 34, No. 1, pp. 70-73, 2002.
Coller, et al. “The pH Dependence of Quantitative Ristocetin-Induced Platelet Aggregation: Theoretical and Practical Implications—A New Device for Maintenance of Platelet-Rich Plasma pH,”Blood, vol. 47, No. 5, pp. 841-854, May 1976.
Supplementary European Search Report dated Aug. 24, 2005.
Barrett, et al. “Growth Factors for Chronic Plantar Fasciitis?”Podiatry Today, pp. 37-42, Nov. 2004.
Eppley, et al. “Platelet Quantification and Growth Factor Analysis for Platelet-Rich Plasma: Implications for Wound Healing,”Plastic and Reconstructive Surgery, pp. 1502-1508, vol. 114, No. 6, Nov. 2004.
Kahn, et al. “Overuse Tendinosis, Not Tendinitis, Part 1: A New Paradigm for a Difficult Clinical Problem,”The Physician and Sportsmedicine, vol. 28, No. 5, 8 pages, May 2000.
Cook, et al. “Overuse Tendinosis, Not Tendinitis, Part 2: Applying the New Approach to Patellar Tendinopathy,”The Physician and Sportsmedicine, vol. 28, No. 6, 12 pages, Jun. 2000.
Khan, et al. “Histopathology of Common Tendinopathies: Update and Implications for Clinical Management,”Clinical Sports Medicine, vol. 27, No. 6, 1999.
Price, et al. “Local Injection Treatment of Tennis Elbow—Hydrocortisone, Triamcinolone and Lignocaine Compared,”British Journal of Rheumatology, vol. 30, pp. 39-44, 1991.
Floryan, et al. “Home Study Program: Intraperative Use of Autologous Platelet-Rich and Platelet-Poor Plasma for Orthopedic Surgery Patients,”Aorn Journal, vol. 80, No. 4, pp. 667-678, Oct. 2004.
Balk, et al. “Outcome of Surgery for Lateral Epicondylitis (Tennis Elbow): Effect of Worker's Compensation,”The American Journal of Orthopedics, pp. 122-126, Mar. 2005.
Harvest Technologies GmbH Brochure for SmartPReP 2, 2002.
Website download from Medtronic, “Magellan” System Features and Benefits, 3 pages, 2004.
Cell Factor Technologies, Inc., Brochure for GPS II Platelet Concentration System, 10 pages, 2004.
Cell Factor Technologies, Inc., Brochure for Boost Demineralizedbonematrix, 6 pages, 2004.
DePuy AcroMed, Inc., Brochure for Symphony Platelet Concentrate System, 10 pages, 2001.
Martinez-Gonzalez, et al. “Do Ambulatory-Use Platelet-Rich Plasma (PRP) Concentrates Present Risks,”Medicina Oral, pp. 375-390, 2002.
Cotter, et al. “A Novel Method for Isolation of Neutrophils from Murine Blood Using Negative Immunomagnetic Separation,”The American Journal of Pathology, vol. 159, pp. 473-481, 2001.
Yang, et al. “Dielectric Properties of Human Leukocyte Subpopulations Determined by Electrorotation as a Cell Separation Criterion,”Biophysical Journal, vol. 76, pp. 3307-3314, Jun. 1999.
Bales, et al. “Microvascular Supply of the Lateral Epicondyle and Common Extensor Origin,”J. Shoulder and Elbow Surgery
Knobbe Martens Olson & Bear LLP
Saucier Sandra E.
LandOfFree
PRP composition and minimally invasive method for treating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PRP composition and minimally invasive method for treating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PRP composition and minimally invasive method for treating... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2769514